Evaluating Itch in Atopic Dermatitis: Perspectives from UK Dermatologists Through a Cross-Sectional Survey and Narrative Review

• by Philip Laws, Alberto Barea, Georgina Fremlin, Charlene Murphy, Daniel Guirguis, Dominika Michno, Kave Shams

• April 21, 2026

Ivarmacitinib Eased Refractory PCA: Case Report

Off-label ivarmacitinib rapidly relieved pruritus and improved skin lesions in a patient with refractory primary cutaneous amyloidosis, according to a case report.

• by Andrea Surnit

• May 20, 2026

• 4 min

FDA Drops Age Limit for Neffy

Needle-free epinephrine expands access for younger children meeting weight criteria

• by Kathryn Wighton

• March 27, 2026

• 2 min

Upadacitinib for Immune Checkpoint Inhibitor–Related Dermatitis: A Nonrandomized Clinical Trial

• by Chengshui Chen, Xinyu Liang, Zheng Peng, Yan Zou, Huijuan He, Xiaoyan Zhang, Yi He, Shixiu Wu

• May 1, 2026